Page last updated: 2024-10-24

chlorambucil and Leukoma

chlorambucil has been researched along with Leukoma in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liebman, SD1
Crocker, AC1
Geiser, CF1

Other Studies

1 other study available for chlorambucil and Leukoma

ArticleYear
Corneal xanthomas in childhood.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1966, Volume: 76, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Child, Preschool; Chlorambucil; Corneal Opacity; Female; Hu

1966